Orion haastaa oikeuteen geneeristen lääkkeiden yhtiöitä
Yhdysvalloissa puolustaakseen entakaponipatenttejaan (Orionin
alkuperälääke Comtan®)
September 13, 2007 13:17 ET
|
Orion
Yhtiön mukaan geneerisen kilpailun toteutuminen ei ole varmaa eikä
siitä ole välitöntä uhkaa
Orion Oyj on aloittanut patenttiloukkausoikeudenkäynnin
Yhdysvalloissa geneeristen lääkkeiden...
Infinera Leads North American Multi-Reach DWDM Optical Market
September 13, 2007 13:17 ET
|
Infinera
SUNNYVALE, Calif., Sept. 13, 2007 (PRIME NEWSWIRE) -- Infinera (Nasdaq:INFN) ranked first in revenue shipments in the key multi-reach DWDM segment of the North American optical networking market in...
Orion sues generic drug companies in the U.S. to enforce patents for entacapone (Orion's proprietary drug Comtan®)
September 13, 2007 13:16 ET
|
Orion Oyj
Company states the realisation of generic competition is neither certain nor imminent
Orion Corporation has filed a patent infringement lawsuit in the United States to enforce U.S....
Orion haastaa oikeuteen geneeristen lääkkeiden yhtiöitä Yhdysvalloissa puolustaakseen entakaponipatenttejaan (Orionin alkuperälääke Comtan®)
September 13, 2007 13:16 ET
|
Orion Oyj
Yhtiön mukaan geneerisen kilpailun toteutuminen ei ole varmaa eikä siitä ole välitöntä uhkaa
Orion Oyj on aloittanut patenttiloukkausoikeudenkäynnin Yhdysvalloissa geneeristen...
New Data to be Presented on Key Basilea Compounds at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
September 13, 2007 13:16 ET
|
Basilea Pharmaceutica AG, Allschwil
Basel, Switzerland, 13th September 2007 - New data on Basilea's late-stage clinical compounds ceftobiprole and isavuconazole, as well as on its research programs, will be presented at the upcoming...
Neue Daten zu Basileas wichtigsten Produktkandidaten und Forschungsprogrammen werden an der ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) präsentiert
September 13, 2007 13:16 ET
|
Basilea Pharmaceutica AG, Allschwil
Basel, 13. September 2007 - Neue Daten sowohl zu Basileas Ceftobiprol und Isavuconazol, die beide in der fortgeschrittenen klinischen Entwicklung sind, als auch zu Forschungsprogrammen werden an...
IMSI/Design Launches Next Generation TurboFLOORPLAN Line
September 13, 2007 13:16 ET
|
IMSI/Design, LLC
NOVATO, Calif., Sept. 13, 2007 (PRIME NEWSWIRE) -- IMSI/Design, the global leader in retail CAD, announced the release of the TurboFLOORPLAN(tm) product line, representing the next generation of...
Charles Drew University Shows Largest Gains in Published Research Among Top 200 Universities With Federal Research Funding
September 13, 2007 13:07 ET
|
The Charles Drew University of Medicine and Science
LOS ANGELES, Sept. 13, 2007 (PRIME NEWSWIRE) -- Topping a list of 200 select U.S. universities, the Charles R. Drew University of Medicine and Science led the academic sector with a 127% growth in...
Gulf Western Petroleum Corporation Announces $3,700,000 Financing
September 13, 2007 13:06 ET
|
Gulf Western Petroleum Corporation
HOUSTON, Sept. 13, 2007 (PRIME NEWSWIRE) -- Gulf Western Petroleum Corporation ("Gulf Western" or "Company") (OTCBB:GWPC) (Frankfurt:GER), is pleased to announce that on September 10, 2007, it entered...
ProElite Acquires King of the Cage, a Leading Global MMA Organization
September 13, 2007 13:02 ET
|
ProElite, Inc.
LOS ANGELES, Sept. 13, 2007 (PRIME NEWSWIRE) -- ProElite, Inc. (Pink Sheets:PELE), a sports entertainment and media company dedicated to producing world-class mixed martial arts (MMA) events, today...
- January 03, 2025 14:00 ET ACC Medlink Solidifies Leadership with 20% Expansion to Fleet of Mercedes Sprinter Vans
- January 03, 2025 13:36 ET Wawa Launches $1 Hot Coffee, $2 Iced Coffee and $3 Monster Energy Drink Offers for Rewards Members